You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 6月24日港股收盤

根據uSMART輿情監測數據,24日港股交易時段,市場關注指數最高的5只股票是阿裏巴巴-SW、理想汽車-W、小鵬汽車-W、藥明生物、思摩爾國際。

6月24日—港股關注排行TOP5

輿情變化榜單

阿裏巴巴-SW

個股K線圖

關注度第一爲阿裏巴巴-SW,該股今日收盤上漲5.46%,報於113.90港元。近5個交易日累計上漲9.00%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆指升309點; 恆生科技指數升140點 阿裏巴巴升逾5% 建發國際集團創新高

港股午評:恆生科技指數漲超3% 阿裏巴巴漲超5% CRO、醫療設備大漲

理想汽車-W

個股K線圖

關注度第二爲理想汽車-W,該股今日收盤上漲5.90%,報於163.30港元。近5個交易日累計上漲22.69%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

招證國際上調理想汽車目標價34%至213港元 指其新車L9爆款可期

美銀證券上調理想汽車目標價至179元 評級「買入」

小鵬汽車-W

個股K線圖

關注度第三爲小鵬汽車-W,該股今日收盤上漲7.32%,報於136.30港元。近5個交易日累計上漲26.56%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

汽車股延續向上升勢 小鵬汽車漲5.75% 但蔚來表現疲軟

港股新能源汽車股繼續走強,小鵬汽車大漲超10%

藥明生物

個股K線圖

關注度第四爲藥明生物,該股今日收盤上漲10.36%,報於77.20港元。近5個交易日累計上漲15.22%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆生指數收漲2.09%報21719點 科技股、醫藥股強勢 藥明生物漲10.36%

藥明生物漲4.79% 申萬宏源首次覆蓋給予買入評級

思摩爾國際

個股K線圖

關注度第五爲思摩爾國際,該股今日收盤上漲7.85%,報於23.35港元。近5個交易日累計上漲14.18%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

思摩爾國際漲5.77% 大和料其受益於PMTA獲批可能性上升

思摩爾國際已大幅上漲近50% FDA下令美國電子煙公司JUUL停止銷售相關產品 行業投資機會什麼時候出現?

此外,監測期內有2只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

6月24日—港股輿情轉折預警

輿情變化榜單

藥明生物

個股K線圖

藥明生物輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

恆生指數收漲2.09%報21719點 科技股、醫藥股強勢 藥明生物漲10.36%

藥明生物漲4.79% 申萬宏源首次覆蓋給予買入評級

理想汽車-W

個股K線圖

理想汽車-W輿情扭轉指數達98,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

招證國際上調理想汽車目標價34%至213港元 指其新車L9爆款可期

美銀證券上調理想汽車目標價至179元 評級「買入」

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account